Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea
Completed
Medicis Pharmaceutical Corporation
Phase 2/Phase 3
2009-02-01
The purpose of this study is to determine whether Clindamycin Phosphate 1.2% And Tretinoin
0.025% Gel are effective and safe in the treatment of papulopustular rosacea.
Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea
Completed
Massachusetts General Hospital
Phase 2/Phase 3
2009-02-01
The purpose of this study is to determine whether Clindamycin Phosphate 1.2% And Tretinoin
0.025% Gel are effective and safe in the treatment of papulopustular rosacea.
Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate
Completed
Igefarma Laboratorios S.A.
Phase 3
2009-03-01
The purpose of this study is to determine the safety and efficacy of association between
tretinoin and clindamycin phosphate on the treatment of acne vulgaris mild and moderate.
Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris
Completed
Medicis Pharmaceutical Corporation
Phase 4
2009-03-01
The purpose of this research study is to evaluate the effectiveness of two different types of
topical acne medication. This study will help to determine if one combined medication results
in better acne improvement than two separate medications for acne.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
